Paul Blair

Paul Blair is an experienced strategic account manager currently employed at Myriad Genetics since August 2021, where responsibilities include overseeing the implementation of hereditary cancer risk assessment protocols. Prior to this role, Paul held various sales positions, including TheraSphere Sales Consultant at Boston Scientific from January 2014 to August 2021, specializing in sales growth for Interventional Oncology solutions. Notable achievements include serving as a Biosurgical Specialist at Genzyme Biosurgery, focusing on consultative sales to surgeons, and a Regional Sales Manager role at Invuity Inc., overseeing a sales team. Paul has a history of exceeding sales targets, demonstrated as a Senior Territory Manager at CR Bard with consistent President's Club recognition, and as an Account Executive at Covidien, where multiple awards highlight top sales performance. Paul holds a Bachelor of Science in Business Administration and Management from the University of Denver.